T.J. Biotechnologies (Tianjin) Ltd. (TJB), registered in TEDA July 2005, is a high-tech Sino-American joint venture, focusing on research and production of antibodies and derivative products, and the HIV detection reagent, immunoassay reagent, the colloid gold fast detection reagent and therapeutic antibodies.
Mr. Liu Lile, G.M. of TJB, has more than 10 years experiences of developing and manufacturing MAb, immunoassay reagents and therapeutic antibodies in U.S.A, with leading MAb production technology and the related intellectual property rights. TJB has planed to produce tens of MAb, PAb and antigens with high specificity and high purity in two years, and more than 500 kinds of antibodies & dozens of Elisa kits derivative products directly into domestic & foreign markets.
TJB pursues to operate with advanced management theory, exert scientific advantage to the most extent based on experienced staff, superior equipment and well-run work environment, offer high-quality raw materials to most domestic downstream biological enterprises especially in Binhai Newly-development Area, and promote the development of domestic biotechnology.